| 1 |
recombinant activated factor VII
(1130 times)
|
Hematology
(445 times)
|
aPCC (80 times)
PT (46 times)
PCC (38 times)
|
1989 Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factor.
|
| 2 |
recombinant FVIIa
(47 times)
|
Hematology
(35 times)
|
FVIIa (8 times)
TF (8 times)
FVIII (7 times)
|
1989 Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor.
|
| 3 |
recombinant human factor VIIa
(16 times)
|
Hematology
(8 times)
|
APTT (2 times)
PT (2 times)
ADAs (1 time)
|
1990 Effect of recombinant human FVIIA on warfarin-induced bleeding in rats.
|
| 4 |
recombinant factor VII activated
(5 times)
|
Hematology
(2 times)
|
APPCs (1 time)
CDBSR (1 time)
EOD (1 time)
|
2007 Activated recombinant factor VII in orthotopic liver transplantation.
|
| 5 |
recombinant human FVIIa
(2 times)
|
Vascular Diseases
(2 times)
|
---
|
1992 Recombinant human factor VIIa (rFVIIa) in a rabbit stasis model.
|
| 6 |
DNA-derived factor VIIa
(1 time)
|
Drug Therapy
(1 time)
|
APTT (1 time)
PT (1 time)
|
1994 Comparison of PT, aPTT, and factor VII values obtained by concurrent sample collection by direct venipuncture and peripheral venous catheters.
|
| 7 |
reacted only with native factor VII and activated factor VII
(1 time)
|
Vascular Diseases
(1 time)
|
---
|
1992 Characterization of a Ca (II)-independent monoclonal antibody that lacks reactivity with Gla-domainless human factor VII.
|
| 8 |
Recombinant and plasma-derived factor products, such as activated factor seven
(1 time)
|
Drug Therapy
(1 time)
|
---
|
2018 Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
|
| 9 |
recombinant DNA-produced factor VIIa
(1 time)
|
Hematology
(1 time)
|
APTT (1 time)
PT (1 time)
|
1993 Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study.
|
| 10 |
recombinant factor VII molecule
(1 time)
|
Hematology
(1 time)
|
---
|
2000 Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.
|
| 11 |
recombinant factor VIIa product
(1 time)
|
Hematology
(1 time)
|
GP (1 time)
|
2008 [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
|
| 12 |
recombinant factor-activated VII
(1 time)
|
Hematology
(1 time)
|
---
|
2010 Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients.
|
| 13 |
recombinant FVIIa concentrate
(1 time)
|
Health Services Research
(1 time)
|
aPCC (1 time)
PCCs (1 time)
|
2010 Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
|
| 14 |
respectively, while recombinant activated FVII
(1 time)
|
Hematology
(1 time)
|
FIX (1 time)
FVIII (1 time)
maxTG (1 time)
|
2009 Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
|
A Search Service for Abbreviation / Long Form